Clinical Trials Logo

Filter by:
NCT ID: NCT02490735 Not yet recruiting - Clinical trials for Esophageal Squamous Cell Carcinoma

CIK in Treating Patients With Esophageal Cancer

Start date: August 2015
Phase: Phase 2
Study type: Interventional

Chemotherapy is the main treatment method for patients with Esophageal Cancer. However, Relapse remains the major cause of treatment failure.Biological therapies such as CIK stimulate the immune system and stop tumor cells from growing. A series of studies reported that cytokine-induced killer cells (CIK) have a broad anti-tumor spectrum. The investigators suppose that CIK will improve the prognosis. Combining chemotherapy with biological therapy may kill more tumor cells. In this study, the patients will be treated with CIK cells after chemotherapy. The purpose of this study is to evaluate the efficacy of CIK for Esophageal Cancer.

NCT ID: NCT02491762 Not yet recruiting - Clinical trials for Breast Reconstruction

The Effect of Breast Reconstruction Surgery Using Tissue Expanders on Respiratory Functions

Start date: August 2015
Phase: N/A
Study type: Observational

This study evaluates the effect of breast reconstruction surgery on respiratory functions. 45 patients elected for unilateral or bilateral breast reconstruction surgery will go through respiratory function examinations a month prior to the surgery, one month after surgery and three months after surgery.

NCT ID: NCT02492152 Not yet recruiting - Vaginal Tearing Clinical Trials

Does the Use of Dianatal Reduce the Rate of Episiotomy and Vaginal Tears in Birth?

Start date: August 2015
Phase: N/A
Study type: Interventional

The purpose of the study is to see whether the use of DIANATAL during active labor, reduces the rates of episiotomy and vaginal tears.

NCT ID: NCT02494752 Not yet recruiting - Lipodystrophy Clinical Trials

Role of Mesenchymal Stem Cells in Fat Grafting

Start date: August 2015
Phase: N/A
Study type: Interventional

Contour deformity of face causes both functional as well as aesthetic problems for the patient. Fat being an autologous tissue source is considered as an ideal soft-tissue filler because it is abundant, readily available, inexpensive, host compatible, and can be harvested easily and repeatedly. However absorption of grafted fat is a major problem resulting in lack of consistency of final clinical outcome. Adipose tissue derived mesenchymal stem cells have the potential to enhance the viability of the grafted fat and the reliability of the final outcome of surgery. In the current study potential of mesenchymal stem cells will be studied by comparing two groups of patients requiring fat grafting for contour deformities of face. Control group will have fat graft with out enrichment with stem cells whereas experimental group will have their fat graft enriched with mesenchymal stem cells. Comparison will be made regarding viability of grafted fat in two groups.

NCT ID: NCT02495012 Not yet recruiting - Clinical trials for ST Segment Elevation Myocardial Infarction

Anfibatide Treatment in STEMI Patients

Start date: August 2015
Phase: Phase 2
Study type: Interventional

A Phase IIb clinical trial to investigate the safety and efficacy of antiplatelet thrombolysin injection for patients with ST Segment Elevation Myocardial Infarction (STEMI) before receiving PCI therapy, in order to provide evidence for Phase III design.

NCT ID: NCT02496845 Not yet recruiting - Clinical trials for Erectile Dysfunction

Safety and Clinical Efficacy of Local Topical Treatment for Erectile Dysfunction

Start date: August 2015
Phase: Phase 1/Phase 2
Study type: Interventional

VL#FIA3-30 is a preparation intended for topical use, applied on the penis, for the treatment of ED.

NCT ID: NCT02497586 Not yet recruiting - Lung Cancer Clinical Trials

Feasibility of Magnetic Resonance Spectroscopy in Lung Cancer

MRS
Start date: August 2015
Phase: N/A
Study type: Interventional

Lung cancer is commonly characterised either with a surgical procedure or by taking a tissue sample with a needle. Unfortunately, these invasive approaches may be unsafe in many patients with lung cancer, who often have co-existing illnesses such as emphysema. Magnetic resonance spectroscopy (MRS) is a type of scan which offers the possibility of assessing tumour function by measuring concentrations of chemicals (metabolites) within the abnormal tissue. It is a well-established technique in imaging brain cancers. It has also been more recently studied in assessing prostate, liver and heart. There has been very little exploration of the potential role of MRS in lung cancer. The proposed feasibility study will recruit 15 patients with proven lung cancer to undergo an MRS scan. The reliability of the technique for metabolite measurement will be determined by comparing repeated scans from the same region in the same tumour. Further scans from different regions in the same tumour, normal lung around the tumour and tumour regions in different patients will be used to look for any patterns in the cancer metabolites which may indicate avenues for potential future research.

NCT ID: NCT02497963 Not yet recruiting - Hypospadias Clinical Trials

Foreskin Graft Tubularized Incised Plate Urethroplasty vs Tubularized Incised Plate for Primary Hypospadias (FGTIP-TIP)

FGTIP-TIP
Start date: August 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the efficacy and safety of tubularized incised plate urethroplasty versus foreskin graft tubularized incised plate urethroplasty in primary hypospadias. This study only included patients with width of urethral plate ≤ 7 mm, width of glans ≤ 14 mm, and urethral plate depth shallow o moderate.

NCT ID: NCT02498756 Not yet recruiting - Melanoma Clinical Trials

Cytokine-induced Killer Study for Patients With Stage II Melanoma

Start date: August 2015
Phase: Phase 2
Study type: Interventional

For investigators' current experimental clinical trial, patients are given 4 injections of ipilimumab, given 3 weeks apart x 4 injections with or without cytokine-induced killer therapy. Investigators propose to test this dual therapy in patients with melanoma who have known stage I, metastatic melanoma. Investigators hypothesize that this form of combinatorial immunotherapy will result in tumor stabilization or shrinkage, significant prolongation of progression-free, disease-free or overall survival compared to the use of ipilimumab alone

NCT ID: NCT02502110 Not yet recruiting - Clinical trials for Paroxysmal Atrial Fibrillation

Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation

Start date: August 2015
Phase: Phase 4
Study type: Interventional

The study will select all recruited patients with paroxysmal atrial fibrillation will be randomly allocated to receive oral rosuvastatin 20mg/day or blank control from 7 days before ablation and last for 3 months. To observe the early relapse of atrial fibrillation and the changes of white blood cell count, hs-C reactive protein (CRP), interleukin (IL)-6 and tumor necrosis factor (TNF)-α, and the changes of safety indicators . This study assumes that the early atrial fibrillation (AF) recurrence will be decreased in patients with paroxysmal AF if rosuvastatin 20mg/d is received from 7 days before surgery in these patients who plan to undergo radiofrequency catheter ablation for consecutive 3 months.